首页> 外文期刊>Biological trace element research >Erythrocyte CuZn superoxide dismutase activity is decreased in iron-deficiency anemia.
【24h】

Erythrocyte CuZn superoxide dismutase activity is decreased in iron-deficiency anemia.

机译:缺铁性贫血中红细胞CuZn超氧化物歧化酶活性降低。

获取原文
获取原文并翻译 | 示例
           

摘要

Iron and copper are essential microminerals that are intimately related. The present study was performed to determine the effect of iron-deficiency anemia (IDA) and treatment with iron on laboratory indicators of copper status. Hemoglobin, mean corpuscular volume erythrocyte Zn protoporphyrin, serum ferritin, serum copper, serum ceruloplasmin, and erythrocyte CuZn-superoxide dismutase (SOD) activity were studied in 12 adult women with IDA before and after iron treatment for 60-90 d (100 mg/d Fe, as ferric polymaltose) and in 27 women with normal iron status. Prior to treatment with iron, serum copper and ceruloplasmin were not different between the groups and treatment with iron did not affect these measures. IDA women, before and after treatment with iron, presented a 2.9- and 2-fold decrease in erythrocyte CuZn-SOD activity compared to women with normal iron status (p < 0.001). Treatment with iron increased erythrocyte CuZn-SOD activity of the IDA group; however, this change was not statistically significant. In conclusion, CuZn-SOD activity is decreased in IDA. Measurement of this enzyme activity is not useful for evaluating copper nutrition in iron-deficient subjects.
机译:铁和铜是必不可少的,与之密切相关的微量元素。进行本研究以确定缺铁性贫血(IDA)和铁治疗对铜状态实验室指标的影响。在12名IDA成年女性中,对铁治疗60-90 d(100 mg / d Fe,如聚麦芽糖铁)和27名铁状态正常的女性。在用铁治疗之前,两组之间的血清铜和铜蓝蛋白没有差异,用铁治疗也不影响这些措施。与铁水平正常的女性相比,IDA妇女在用铁治疗前后,其红细胞CuZn-SOD活性降低了2.9倍和2倍(p <0.001)。铁治疗增加了IDA组的红细胞CuZn-SOD活性;但是,此变化在统计上并不显着。总之,IDA中的CuZn-SOD活性降低。此酶活性的测量对评估铁缺乏症患者的铜营养没有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号